United Kingdom, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure
United Kingdom, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure
$1,995.00
This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries
Publisher: Medtech Insight
- Description
- Contents
- Samples
This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden. Among the diseases/disorders covered by this report are Alzheimer’s disease, bipolar disorder, depression, epilepsy, multiple sclerosis (MS), Parkinson’s disease, schizophrenia, and stroke.
Table of Contents
1. OVERVIEW OF NEUROLOGICAL DISORDERS………………………………….1-1
1.1 Alzheimer’s Disease………………………………………………………………..1-1
1.2 Amyotrophic Lateral Sclerosis…………………………………………………..1-3
1.3 Arteriovenous Malformation………………………………………………………1-4
1.4 Bipolar Disorder………………………………………………………………………1-5
1.5 Depression…………………………………………………………………………….1-6
1.6 Epilepsy…………………………………………………………………………………1-6
1.7 Huntington’s Disease……………………………………………………………….1-7
1.8 Hydrocephalus………………………………………………………………………..1-8
1.9 Multiple Sclerosis…………………………………………………………………….1-9
1.10 Parkinson’s Disease………………………………………………………………1-10
1.11 Schizophrenia……………………………………………………………………….1-11
1.12 Stroke………………………………………………………………………………….1-12
Exhibit 1-1: United Kingdom, Neurosurgery, Procedure Volumes Forecast, by Type, 2010-2016…………………………………………………………………1-2
Exhibit 1-2: United Kingdom, Neurological Diseases/Disorders, Incidence and Prevalence………………………………………………………1-14
2. NEUROLOGICAL AND PSYCHIATRIC DISORDERS…………………………..2-1
2.1 Alzheimer’s Disease and Dementia……………………………………………2-1
2.1.1 Etiology……………………………………………………………………2-1
2.1.2 Epidemiology……………………………………………………………2-2
2.2 Amyotrophic Lateral Sclerosis…………………………………………………..2-3
2.2.1 Etiology……………………………………………………………………2-3
2.2.2 Epidemiology……………………………………………………………2-7
2.3 Bipolar Disorder………………………………………………………………………2-8
2.3.1 Etiology……………………………………………………………………2-8
2.3.2 Epidemiology………………………………………………………….2-10
2.4 Cerebrovascular Disorders……………………………………………………..2-11
2.4.1 Arteriovenous Malformation………………………………………2-11
2.4.1.1 Etiology…………………………………………………..2-13
2.4.1.2 Epidemiology……………………………………………2-13
2.4.2 Stroke……………………………………………………………………2-14
2.4.2.1 Etiology…………………………………………………..2-14
2.4.2.2 Epidemiology……………………………………………2-17
2.5 Depression…………………………………………………………………………..2-19
2.5.1 Etiology………………………………………………………………….2-19
2.5.2 Epidemiology………………………………………………………….2-20
2.6 Epilepsy……………………………………………………………………………….2-21
2.6.1 Etiology………………………………………………………………….2-23
2.6.2 Epidemiology………………………………………………………….2-24
2.7 Huntington’s Disease……………………………………………………………..2-24
2.7.1 Etiology………………………………………………………………….2-26
2.7.2 Epidemiology………………………………………………………….2-26
2.8 Hydrocephalus………………………………………………………………………2-27
2.8.1 Etiology………………………………………………………………….2-29
2.8.2 Epidemiology………………………………………………………….2-29
2.9 Multiple Sclerosis…………………………………………………………………..2-30
2.9.1 Etiology………………………………………………………………….2-32
2.9.2 Epidemiology………………………………………………………….2-34
2.10 Myasthenia Gravis…………………………………………………………………2-36
2.10.1 Etiology………………………………………………………………….2-36
2.10.2 Epidemiology………………………………………………………….2-38
2.11 Parkinson’s Disease………………………………………………………………2-40
2.11.1 Etiology………………………………………………………………….2-41
2.11.2 Epidemiology………………………………………………………….2-42
2.12 Schizophrenia……………………………………………………………………….2-42
2.12.1 Etiology………………………………………………………………….2-44
2.12.2 Epidemiology………………………………………………………….2-45
Exhibit 2-1: 2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender…………………………………………2-4
Exhibit 2-2: 2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender………………………………………2-5
Exhibit 2-3: 2010, United Kingdom and Europe, Alzheimer’s Disease, Comparative Incidence and Prevalence……………………………………..2-6
Exhibit 2-4: 2010, United Kingdom and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence……………………………………..2-9
Exhibit 2-5: 2010, United Kingdom and Europe, Bipolar Disorder, Comparative Incidence and Prevalence……………………………………2-12
Exhibit 2-6: 2010, United Kingdom and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence……………………………………2-15
Exhibit 2-7: 2010, United Kingdom and Europe, Stroke, Comparative Incidence and Prevalence……………………………………2-18
Exhibit 2-8: 2010, United Kingdom and Europe, Depression, Comparative Prevalence………………………………………………………..2-22
Exhibit 2-9: 2010, United Kingdom and Europe, Epilepsy, Comparative Incidence and Prevalence……………………………………2-25
Exhibit 2-10: 2010, United Kingdom and Europe, Huntington’s Disease, Comparative Incidence and Prevalence……………………………………2-28
Exhibit 2-11: 2010, United Kingdom and Europe, Hydrocephalus, Comparative Incidence and Prevalence……………………………………2-31
Exhibit 2-12: 2010, United Kingdom and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence……………………………………2-37
Exhibit 2-13: 2010, United Kingdom and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence……………………………………2-39
Exhibit 2-14: 2010, United Kingdom and Europe, Parkinson’s Disease, Comparative Incidence and Prevalence……………………………………2-43
Exhibit 2-15: 2010, United Kingdom and Europe, Schizophrenia, Comparative Incidence and Prevalence……………………………………2-47
3. NEUROSURGICAL PROCEDURES…………………………………………………..3-1
3.1 The Brain……………………………………………………………………………….3-1
3.1.1 The Cerebrum………………………………………………………….3-1
3.1.2 The Cerebellum………………………………………………………..3-2
3.1.3 The Brainstem………………………………………………………….3-2
3.1.4 The Meninges…………………………………………………………..3-4
3.1.5 The Ventricular System……………………………………………..3-4
3.1.6 Cerebrospinal Fluid…………………………………………………..3-6
3.1.7 The Hypothalamus……………………………………………………3-6
3.1.8 The Pineal Gland………………………………………………………3-6
3.1.9 The Pituitary Gland……………………………………………………3-8
3.2 Selected Diseases/Disorders of the Central Nervous System and the Peripheral Nervous System…………………………………………..3-8
3.2.1 Hydrocephalus…………………………………………………………3-8
3.2.2 Movement, Seizure, and Tremor Disorders…………………3-10
3.2.2.1 Alzheimer’s Disease………………………………….3-10
3.2.2.2 Epilepsy…………………………………………………..3-12
3.2.2.3 Multiple Sclerosis……………………………………..3-14
3.2.2.4 Parkinson’s Disease………………………………….3-15
3.2.2.5 Deep Brain Stimulation………………………………3-16
3.2.2.6 Stereotactic Radiosurgery………………………….3-18
3.2.3 Traumatic Brain Injury……………………………………………..3-20
3.3 The Cerebrovascular System and Selected Diseases/Disorders….3-22
3.3.1 The Arterial System…………………………………………………3-22
3.3.2 The Venous System………………………………………………..3-25
3.3.3 Aneurysm………………………………………………………………3-25
3.3.4 Arteriovenous Malformation………………………………………3-27
3.3.5 Stroke……………………………………………………………………3-30
Exhibit 3-1: Structural Relationship between the Cerebrum, Cerebellum, and Brainstem………………………………………………………………………..3-3
Exhibit 3-2: Structure of the Meninges………………………………………………………..3-5
Exhibit 3-3: Ventricles of the Brain……………………………………………………………..3-7
Exhibit 3-4: United Kingdom, Ventricular Shunting and Ventriculostomy, Procedure Volumes Forecast, 2010-2016…………………………………3-11
Exhibit 3-5: United Kingdom, Deep Brain Stimulation and Stereotactic Radiosurgery, Procedure Volumes Forecast, 2010-2016……………………………………………………………………………3-19
Exhibit 3-6: United Kingdom, Evacuation of Subdural Hematoma, Procedure Volumes Forecast, 2010-2016…………………………………3-23
Exhibit 3-7: United Kingdom, Cerebral Aneurysm Clipping, Procedure Volumes Forecast, 2010-2016…………………………………3-28
Exhibit 3-8: United Kingdom, Arteriovenous Malformation Embolization, Procedure Volumes Forecast, 2010-2016…………………………………3-31
Exhibit 3-9: United Kingdom, Carotid Endarterectomy and Carotid Artery Stenting, Procedure Volumes Forecast, 2010-2016……………………………………………………………………………3-35
Figure: United Kingdom, Neurosurgery, Procedure Volumes Forecast, by Type, 2010-2016
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Germany, Neurological Market Opportunities: Disease Incidence and Prevalence,... 
Sign up to the